Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | VERA | IDYA | ||
| Company | Dicerna Pharmaceutic | Vera Therapeutics Inc Cl A | Ideaya Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 42.01 | 33.72 | ||
| High | 38.24 | 42.82 | 34.04 | ||
| Low | 38.21 | 41.53 | 33.09 | ||
| Latest | 38.22 | 41.61 | 33.60 | ||
| Change | +0.22 | -0.69 | -0.31 | ||
| % Change | +0.58% | -1.63% | -0.91% | ||
| Volume | 5,568,900 | 755,200 | 843,900 | ||
| 20-Day Average Volume | 3,647,665 | 1,240,790 | 1,751,200 | ||
| Previous Close | 38.00 | 42.30 | 33.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 41.19 | 31.96 | ||
| 20-Day Raw Stochastic | 90.72% | 40.77% | 47.25% | ||
| 20-Day Relative Strength | 80.40 | 50.10 | 53.53 | ||
| Weighted Alpha | +35.17 | +60.01 | +65.74 | ||
| Today's Opinion | 88% Buy | 40% Buy | 24% Buy | ||
| Previous Opinion | 72% Buy | 40% Buy | 40% Buy | ||
| Last Month's Opinion | 24% Buy | 40% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | -4.80% since 04/13/26 | +2.38% since 04/13/26 | ||
| Low | 37.81 on 12/21/21 | 41.52 on 04/16/26 | 30.71 on 04/14/26 | ||
| High | 38.24 on 12/27/21 | 45.73 on 04/14/26 | 34.67 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +2.66% since 03/20/26 | +2.60% since 03/20/26 | ||
| Low | 37.78 on 12/10/21 | 37.90 on 03/30/26 | 29.57 on 03/24/26 | ||
| High | 38.26 on 12/03/21 | 47.00 on 04/10/26 | 38.10 on 04/13/26 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -7.18% since 01/20/26 | -6.01% since 01/20/26 | ||
| Low | 19.06 on 10/06/21 | 37.51 on 03/19/26 | 29.47 on 02/17/26 | ||
| High | 38.26 on 12/03/21 | 49.33 on 01/22/26 | 38.10 on 04/13/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | +37.78% since 10/20/25 | +10.13% since 10/20/25 | ||
| Low | 19.06 on 10/06/21 | 23.05 on 11/06/25 | 28.17 on 10/23/25 | ||
| High | 40.14 on 07/20/21 | 56.05 on 12/24/25 | 39.28 on 01/07/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,018,359 | 2,977,773 | ||
| Shares Outstanding, K | 78,129 | 71,356 | 87,814 | ||
| Annual Sales | 164,310,000 | 0 | 218,710,000 | ||
| Annual Net Income | -112,750,000 | -299,610,000 | -113,700,000 | ||
| Last Quarter Sales | 62,950,000 | 0 | 10,880,000 | ||
| Last Quarter Net Income | -17,070,000 | -91,100,000 | -83,270,000 | ||
| 60-Month Beta | 0.80 | 1.17 | 0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -1.39 on 02/26/26 | -0.94 on 02/17/26 | ||
| Latest Earnings Date | 02/24/22 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||